SOPHiA GENETICS SA
SOPHSophia Genetics SA is a Swiss-founded data-driven medicine software company with headquarters in Rolle, Switzerland and Boston, Massachusetts, as well as offices in France. It provides genomic and radiomic, and multimodal analysis for hospitals, laboratories, and biopharma institutions.
Drugs in Pipeline
6
Phase 3 Programs
2
Upcoming Catalysts
1
Next Catalyst
Aug 4, 2026
6wMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
PRO-122
Primary Open Angle Glaucoma
PRO-148
Dry Eye
Nanodrop®
Dry Eye
PRO-155
Cataract
dorzolamide-timolol-brimonidine
Primary Open Angle Glaucoma
PRO-148 Ophthalmic Solution
Dry Eye Syndrome
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
PRO-122 | Phase 3 | Primary Open Angle Glaucoma | - | - |
PRO-148 | Phase 3 | Dry Eye | - | - |
Nanodrop® | Phase 2 | Dry Eye | - | - |
PRO-155 | Phase 2 | Cataract | - | - |
dorzolamide-timolol-brimonidine | Phase 2 | Primary Open Angle Glaucoma | - | - |
PRO-148 Ophthalmic Solution | Phase 2 | Dry Eye Syndrome | - | - |